Ageism in the COVID-19 pandemic: age-based discrimination in triage decisions and beyond.


Journal

History and philosophy of the life sciences
ISSN: 1742-6316
Titre abrégé: Hist Philos Life Sci
Pays: Switzerland
ID NLM: 8003052

Informations de publication

Date de publication:
13 Jul 2021
Historique:
received: 15 12 2020
accepted: 18 06 2021
entrez: 14 7 2021
pubmed: 15 7 2021
medline: 22 7 2021
Statut: epublish

Résumé

Ageism has unfortunately become a salient phenomenon during the COVID-19 pandemic. In particular, triage decisions based on age have been hotly discussed. In this article, I first defend that, although there are ethical reasons (founded on the principles of benefit and fairness) to consider the age of patients in triage dilemmas, using age as a categorical exclusion is an unjustifiable ageist practice. Then, I argue that ageism during the pandemic has been fueled by media narratives and unfair assumptions which have led to an ethically problematic group homogenization of the older population. Finally, I conclude that an intersectional perspective can shed light on further controversies on ageism and triage in the post-pandemic future.

Identifiants

pubmed: 34258692
doi: 10.1007/s40656-021-00441-3
pii: 10.1007/s40656-021-00441-3
pmc: PMC8276843
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91

Subventions

Organisme : "la Caixa" Foundation
ID : LCF/BQ/DR20/11790005

Informations de copyright

© 2021. Springer Nature Switzerland AG.

Références

Am J Bioeth. 2020 Jul;20(7):106-109
pubmed: 32716774
Hastings Cent Rep. 1997 Mar-Apr;27(2):34-42
pubmed: 9131351
Hist Philos Life Sci. 2020 Oct 13;42(4):49
pubmed: 33048278
J Aging Soc Policy. 2020 Jul-Oct;32(4-5):499-505
pubmed: 32529918
Minerva Anestesiol. 2020 May;86(5):469-472
pubmed: 32242647
Int J Equity Health. 2020 May 19;19(1):72
pubmed: 32430077
Science. 2006 May 12;312(5775):854-5
pubmed: 16690847
Hist Philos Life Sci. 2021 Jun 14;43(2):83
pubmed: 34125318
Acute Med Surg. 2017 Jul 14;4(4):379-384
pubmed: 29123897
Swiss Med Wkly. 2020 Apr 30;150:w20269
pubmed: 32352150
Am J Bioeth. 2020 Jul;20(7):28-36
pubmed: 32420822
Hastings Cent Rep. 2021 Jan;51(1):13-15
pubmed: 33320366
J Bioeth Inq. 2020 Dec;17(4):601-605
pubmed: 32840832
Front Public Health. 2021 Apr 12;9:589244
pubmed: 33912526
Disaster Med Public Health Prep. 2008 Sep;2 Suppl 1:S4-7
pubmed: 18769265

Auteurs

Jon Rueda (J)

Department of Philosophy 1 and FiloLab-UGR Scientific Unit of Excellence, University of Granada, Granada, Spain. ruetxe@ugr.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH